Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep 29:2:17040.
doi: 10.1038/sigtrans.2017.40. eCollection 2017.

Targeting cellular pathways in glioblastoma multiforme

Affiliations
Review

Targeting cellular pathways in glioblastoma multiforme

Joshua R D Pearson et al. Signal Transduct Target Ther. .

Abstract

Glioblastoma multiforme (GBM) is a debilitating disease that is associated with poor prognosis, short median patient survival and a very limited response to therapies. GBM has a very complex pathogenesis that involves mutations and alterations of several key cellular pathways that are involved in cell proliferation, survival, migration and angiogenesis. Therefore, efforts that are directed toward better understanding of GBM pathogenesis are essential to the development of efficient therapies that provide hope and extent patient survival. In this review, we outline the alterations commonly associated with GBM pathogenesis and summarize therapeutic strategies that are aimed at targeting aberrant cellular pathways in GBM.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of RTK activation and the resultant downstream signaling. Black arrows indicate activation whereas red arrows indicate inhibition.
Figure 2
Figure 2
A schematic representation of the role of p53 and pRB signaling in response to stress signals. Black arrows indicate activation whereas red arrows indicate inhibition.

References

    1. Ostrom QT, Gittleman H, Stetson L, Virk SM, Barnholtz-Sloan JS. Epidemiology of gliomas. In: Raizer J, Parsa A (eds). Current Understanding and Treatment of Gliomas 1st edn. Springer International Publishing: Switzerland, 2015, pp 1–14.
    1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–996. - PubMed
    1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359: 492–507. - PubMed
    1. Ohgaki H. Epidemiology of brain tumors. Methods Mol Biol 2009; 472: 323–342. - PubMed
    1. Martinez R, Schackert G, Yaya-Tur R, Rojas-Marcos I, Herman JG, Esteller M. Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme. J Neurooncol 2007; 83: 91–93. - PubMed

Publication types